跳至主要内容
临床试验/NCT03718637
NCT03718637招募中4 期

Efficacy Evaluation of Surgical Treatment Using Bioinductive Implant for Tennis Elbow (Lateral Epicondylitis)

Henry Ford Health System1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2019年4月17日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
招募中
入组人数
40
试验地点
1
主要终点
Visual Analog Scale (VAS) for Pain

研究概览

简要总结

The investigators are testing the efficacy of a new, FDA-approved bioinductive patch in lateral epicondylitis (tennis elbow) patients. A bioinductive patch is an implant that may foster tendon regrowth and healing following surgery. Patients will be randomize into one of two groups: control and investigational. Patients in the "control group" will receive the normal surgery for patients who do not respond to physical therapy, lifestyle changes, and anti-inflammatory treatment. Patients in the "experimental group" will receive the same surgical treatment, with the addition of the bioinductive patch. This patch will be implanted during surgery. Then, using a combination of ultrasound studies and other measures, the investigators will assess how well the patch works compared to surgery alone.

详细描述

A bioinductive patch is an implant that may foster tendon regrowth and healing following surgery. Patients will be randomized into one of two groups: control and investigational. All surgical patients will have failed non surgery options for 6 months (physical therapy, lifestyle changes, anti-inflammatories, injections) Patients in the "control group" will receive the standard surgery (open lateral epicondylectomy) . Patients in the "experimental group" will receive the same surgical treatment, with the addition of the bioinductive patch. This patch will be implanted during surgery. Then, using a combination of ultrasound studies and other measures, the investigators will assess how well the patch works compared to surgery alone.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

盲法说明

The study participant will not have knowledge of which treatment group he/she is randomized into for the duration of the study. Because the care provider/investigator will be required to implant the bioinductive patch, the physician will know into which treatment group each patient falls.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Diagnosis of lateral epicondylitis (tennis elbow) that has failed conservative treatment (Physical therapy, activity change, anti-inflammatory treatment.

排除标准

  • Previous surgery on the currently-affected elbow.

研究组 & 干预措施

Control

Active Comparator

Surgical treatment alone, consisting of tendon debridement and repair. Ultrasounds preoperatively and 6 months postoperatively.

干预措施: Lateral Epicondylectomy (Procedure)

Control

Active Comparator

Surgical treatment alone, consisting of tendon debridement and repair. Ultrasounds preoperatively and 6 months postoperatively.

干预措施: Ultrasound Imaging (Radiation)

Experimental

Experimental

Identical surgical treatment plus Smith & Nephew bio-inductive patch implant. Ultrasounds preoperatively and 6 months postoperatively.

干预措施: Smith & Nephew Bioinductive Implant (Biological)

Experimental

Experimental

Identical surgical treatment plus Smith & Nephew bio-inductive patch implant. Ultrasounds preoperatively and 6 months postoperatively.

干预措施: Lateral Epicondylectomy (Procedure)

Experimental

Experimental

Identical surgical treatment plus Smith & Nephew bio-inductive patch implant. Ultrasounds preoperatively and 6 months postoperatively.

干预措施: Ultrasound Imaging (Radiation)

结局指标

主要结局

Visual Analog Scale (VAS) for Pain

时间窗: Preoperative to 1 year postoperative

Traditional 1 to 10, subjective rating of pain the patient is experiencing

PROMIS CAT Scores

时间窗: Preoperative to 1 year postoperative

A short 5 minute survey asking questions about physical function, pain, and mental health

Range of Motion

时间窗: Preoperative to 1 year

Standard range of motion values collected by the surgeon during preoperative and followup visits

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Stephanie Muh, MD

Deputy Service Chief, Principal Investigator

Henry Ford Health System

研究点 (1)

Loading locations...

相似试验